Carla Lema Tome

Title: Carla Lema Tome: Innovator in Cancer Treatment

Introduction

Carla Lema Tome is a prominent inventor based in Winston-Salem, NC (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 3 patents, her work focuses on developing constructs that target tumors effectively.

Latest Patents

Among her latest patents is the invention titled "EPHA3 and multi-valent targeting of tumors." This patent describes a construct that includes an EphA3, EphA2, and/or EphB2 binding ligand, combined with at least one effector molecule. The effector molecule may consist of a therapeutic agent, a nanoparticle, a detectable group, a lipid, or a liposome. In some instances, the construct is designed as a fusion protein or a covalent conjugate. Additionally, the patent outlines methods for using these constructs to treat cancer, showcasing her commitment to advancing medical science.

Career Highlights

Carla Lema Tome is affiliated with Wake Forest University, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize cancer therapies and improve patient outcomes.

Collaborations

Carla collaborates with notable colleagues, including Waldemar Debinski and Sara Ferluga, who contribute to her research initiatives and enhance the impact of her inventions.

Conclusion

Carla Lema Tome is a dedicated inventor whose work in cancer treatment exemplifies innovation and collaboration. Her patents reflect a deep commitment to improving therapeutic strategies for patients facing cancer.